Alessandro Pieri, Scientific Leader at GSK Vaccine TRD MDS, graduated in biology in 1993 and obtained a PhD in Biochemistry in 1998 at Università di Firenze (Italy). He has more than 20 years of experience in the field of Research and Development in Vaccines: 5 years as a Scientist in Research Centers and as a Purification Process Development Specialist in Technical Development at Chiron Vaccines; 6 years as a Downstream Development Manager at Novartis V&D; and 6 years as a Downstream and Upstream Development Manager and Scientific Leader at GSK Vaccines. His current and previous research interests include: Upstream and Downstream Process Development, Technical Transfer, Process Understanding and Process Characterization, Quality By Design, and ICH Q12.
Alessandro Pieri, Scientific Leader at GSK Vaccine TRD MDS, graduated in biology in 1993 and obtained a PhD in Biochemistry in 1998 at Università di Firenze (Italy). He has more than 20 years of experience in the field of Research and Development in Vaccines: 5 years as a Scientist in Research Centers and as a Purification Process Development Specialist in Technical Development at Chiron Vaccines; 6 years as a Downstream Development Manager at Novartis V&D; and 6 years as a Downstream and Upstream Development Manager and Scientific Leader at GSK Vaccines. His current and previous research interests include: Upstream and Downstream Process Development, Technical Transfer, Process Understanding and Process Characterization, Quality By Design, and ICH Q12.